Noam B. Fischman, Esq.
Noam Fischman is a trusted guide for healthcare providers, pharmaceutical companies, life sciences companies, and related healthcare vendors, leading clients through cases in federal and state courts, as well as government investigations and matters involving regulatory agencies. Noam has a specific focus on managing risk related to fraud and alleged false claims, and fiduciary duty-related issues for hospitals and hospital systems, behavioral health centers, ambulance companies, and skilled nursing facilities. Additionally, Noam has focused a significant portion of his practice to managing deal-related due diligence for clients engaging in corporate mergers and other transformational transactions, and advising clients about – and litigating when necessary – post-closing deal disputes.
Outside of the healthcare industry, for more than twenty years, Noam has managed commercial litigation needs for clients ranging from contract disputes to commercial fraud matters to challenges to government action under the Administrative Procedure Act, among other types of cases. Noam routinely advises clients on issues related to the Foreign Corrupt Practices Act and manages related due diligence and investigations. He has litigated RICO matters and has guided clients through employment-related litigation and litigation issues associated with the EB-5 foreign investor program. He has also served for years in the role of outside general counsel and has advised several Boards of Directors on matters related to corporate and non-profit governance.
Noam leverages his industry-specific knowledge and experience to provide clients with practical advice aimed at avoiding disputes before they arise. If disputes are unavoidable, Noam pivots to innovative and goal-oriented litigation strategies aimed at maximizing leverage for his clients while simultaneously seeking to minimize the impact of litigation of the client’s business.